Terms: = Gastric cancer AND CTLA4, ALPS5, CD, CD152, CELIAC3, CTLA-4, GRD4, GSE, IDDM12 AND Prognosis
93 results:
1. Predictors of 1-year mortality after gastrectomy for gastric cancer.
Sekimoto A; Miyake H; Nagai H; Yoshioka Y; Yuasa N
World J Surg; 2024 Jan; 48(1):138-150. PubMed ID: 38686784
[TBL] [Abstract] [Full Text] [Related]
2. A degradome-related signature for predicting the prognosis and immunotherapy benefit in stomach adenocarcinoma based on machine learning procedure.
Deng Z; Feng Q; Zhao D; Huang Z
Medicine (Baltimore); 2024 Apr; 103(15):e37728. PubMed ID: 38608069
[TBL] [Abstract] [Full Text] [Related]
3. Machine learning-based cell death signature for predicting the prognosis and immunotherapy benefit in stomach adenocarcinoma.
Li F; Feng Q; Tao R
Medicine (Baltimore); 2024 Mar; 103(10):e37314. PubMed ID: 38457593
[TBL] [Abstract] [Full Text] [Related]
4. Identification of ferroptosis-related subtypes, characteristics of TME infiltration and development of prognostic models in gastric cancer.
Tang X; Yu Y; Liu N; Su Y; Zhang K; Zhai Z; Chen C; Sun W; Chen D; Ling R
Int Immunopharmacol; 2024 Mar; 130():111610. PubMed ID: 38402832
[TBL] [Abstract] [Full Text] [Related]
5. Identification of necroptosis-associated miRNA signature for predicting prognosis and immune landscape in stomach adenocarcinoma.
Zhang S; Liu S; Yue C; Liu Y; Zheng G; Zhang Y
Exp Cell Res; 2024 Mar; 436(1):113948. PubMed ID: 38307189
[TBL] [Abstract] [Full Text] [Related]
6. Identification of CERS5 as a molecular biomarker in pan-cancer through multiple omics integrative analysis.
Wang S; Yang J; Huang W; Yu Z; Mao Y; Feng Y; Chen J
Cell Signal; 2024 Apr; 116():111054. PubMed ID: 38244710
[TBL] [Abstract] [Full Text] [Related]
7. CRABP2 regulates infiltration of cancer-associated fibroblasts and immune response in melanoma.
Zeng S; Chen XI; Yi Q; Thakur A; Yang H; Yan Y; Liu S
Oncol Res; 2023; 32(2):261-272. PubMed ID: 38186580
[TBL] [Abstract] [Full Text] [Related]
8. Effect of sarcopenia on short-term and long-term outcomes of older patients with locally advanced gastric cancer: a multicenter study.
Zheng ZF; Lin GT; Zhong Q; Wu D; Lu J; Wang JB; Chen QY; Lin JX; Cao LL; Lin M; Zheng SP; Xie JW; Zheng CH; Huang CM; Li P
Surg Endosc; 2024 Mar; 38(3):1151-1162. PubMed ID: 38082017
[TBL] [Abstract] [Full Text] [Related]
9. Immune activity score to assess the prognosis, immunotherapy and chemotherapy response in gastric cancer and experimental validation.
Wu X; Zhou F; Cheng B; Tong G; Chen M; He L; Li Z; Yu S; Wang S; Lin L
PeerJ; 2023; 11():e16317. PubMed ID: 38025711
[TBL] [Abstract] [Full Text] [Related]
10. Immune checkpoints signature-based risk stratification for prognosis of patients with gastric cancer.
Wu Z; Li G; Wang W; Zhang K; Fan M; Jin Y; Lin R
Cell Signal; 2024 Jan; 113():110976. PubMed ID: 37981068
[TBL] [Abstract] [Full Text] [Related]
11. Mechanisms and biomarkers of immune-related adverse events in gastric cancer.
Ding P; Liu P; Meng L; Zhao Q
Eur J Med Res; 2023 Nov; 28(1):492. PubMed ID: 37936161
[TBL] [Abstract] [Full Text] [Related]
12. Integrated analysis of single-cell and bulk RNA-sequencing data reveals the prognostic value and molecular function of THSD7A in gastric cancer.
Shen K; Chen B; Yang L; Gao W
Aging (Albany NY); 2023 Oct; 15(21):11940-11969. PubMed ID: 37905960
[TBL] [Abstract] [Full Text] [Related]
13. Multi-omics characteristics of tumor-associated macrophages in the tumor microenvironment of gastric cancer and their exploration of immunotherapy potential.
Cao F; Liu Y; Cheng Y; Wang Y; He Y; Xu Y
Sci Rep; 2023 Oct; 13(1):18265. PubMed ID: 37880233
[TBL] [Abstract] [Full Text] [Related]
14. Clinical implications of RAB13 expression in pan-cancer based on multi-databases integrative analysis.
Zhang XD; Liu ZY; Luo K; Wang XK; Wang MS; Huang S; Li RF
Sci Rep; 2023 Oct; 13(1):16859. PubMed ID: 37803063
[TBL] [Abstract] [Full Text] [Related]
15. Tumor cell-expressed lipolysis-stimulated lipoprotein receptor negatively regulates T-cell function.
Funauchi M; Serada S; Hiramatsu K; Funajima E; Kanda M; Nagase Y; Nakagawa S; Ohkawara T; Fujimoto M; Suzuki Y; Ueda Y; Kimura T; Naka T
Int J Cancer; 2024 Feb; 154(3):425-433. PubMed ID: 37728485
[TBL] [Abstract] [Full Text] [Related]
16. [Study of immunophenotypic characteristics, clinicopathological parameters and prognosis in gastric cancer microenvironment].
Wu Y; Chen YQ; Shi TG; Tan NJ; Chen WC
Zhonghua Yi Xue Za Zhi; 2023 Sep; 103(35):2786-2794. PubMed ID: 37723053
[No Abstract] [Full Text] [Related]
17. DNA methylation-related lncRNAs predict prognosis and immunotherapy response in gastric cancer.
Guo X; Wang Y; Zha L; Li H; Qian K
J Cancer Res Clin Oncol; 2023 Nov; 149(16):14745-14760. PubMed ID: 37592033
[TBL] [Abstract] [Full Text] [Related]
18. Genetically engineered neural stem cells expressing cytosine deaminase and interferon-beta enhanced T cell-mediated antitumor immunity against gastric cancer in a humanized mouse model.
Choi Y; Lee HK; Ahn D; Nam MW; Go RE; Choi KC
Life Sci; 2023 Sep; 328():121866. PubMed ID: 37331506
[TBL] [Abstract] [Full Text] [Related]
19. Apolipoprotein C1 promotes tumor progression in gastric cancer.
Gu Q; Zhan T; Guan X; Lai C; Lu NA; Wang G; Xu L; Gao X; Zhang J
Oncol Res; 2023; 31(3):287-297. PubMed ID: 37305389
[TBL] [Abstract] [Full Text] [Related]
20. Prognostic significances of PD-L1- and ctla-4-positive T cells and positive correlations of immunosuppressive marker expression between cancer tissue and peripheral blood in patients with gastric cancer.
Lee KH; Kim SJ; Woo JS; Lee SY; Jhun J; Moon J; Jung YJ; Cho ML; Song KY
Front Immunol; 2023; 14():1138743. PubMed ID: 37153541
[TBL] [Abstract] [Full Text] [Related]
[Next]
